SUBSCRIBE: Print / Digital / eNewsletter
A UMass Memorial telehealth-based program connects patients with credentialed clinicians who can prescribe medication-assisted treatment for opioid use disorder.
Optimism is strong around the pharmacy industry as we head into a new decade, and many believe that 2020 is going to be a pivotal year for the industry.
Patients with diabetes now have access to more technology than ever before to help them manage the chronic disease, but the devices can be complicated for patients to use.
Technology has long pushed the limits of the possible in pharmacy.
As participation in the 340B program becomes more of a political football especially in the upcoming 2020 election year, it is even more important to be mindful of access requirements and compliance tracking.
A report issued this week at the 2019 American Society of Health System Pharmacists Midyear Clinical Meeting & Exposition from McKesson RxO detailed the major trends and challenges in health care ahead.
RDTs can improve outcomes and reduce unnecessary antibiotic use.
How to set up a new technology for success and get employees—and patients—excited about it.
Prescription drone delivery services will be a chain-shipment showdown.
New and old non-opioid pain management solutions.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
